In addition, 3-BrPA sensitized human breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via the p-AMPK-mediated upregulation of death receptor 5 (DR5) [106], similar to the mechanism described in a previous study [86]. This evidence concerns the gene TNFRSF10B and breast carcinoma.